PM479. Clinical and Functional Response to Paliperidone Palmitate in Early Schizophrenia – A Retrospective Observational Study in Newly Diagnosed Patients Treated Over a 12-Month P...

por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger
Publicado 2016

PM480. Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - A Retrospective Observational Study

por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger
Publicado 2016

PM481. Tolerability, safety and treatment response of flexibly-dosed paliperidone palmitate in patients hospitalized for an exacerbation of schizophrenia

por Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Hargarter, Ludger, Lahaye, Marjolein
Publicado 2016

Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia

por Vauth, Roland, Carpiniello, Bernardo, Turczyński, Jacek, Ivanov, Mikhail, Cherubin, Pierre, Lahaye, Marjolein, Schreiner, Andreas
Publicado 2020

Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

por Emsley, Robin, Hargarter, Ludger, Bergmans, Paul, Uglešić, Boran, Sengül, Abdullah Cem, Petralia, Antonino, Khannanova, Angelina, Cherubin, Pierre, Schreiner, Andreas
Publicado 2017

Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional st...

por Schreiner, Andreas, Caspi, Asaf, Bergmans, Paul, Cherubin, Pierre, Keim, Sofia, Lara, Elsa, Pinchuk, Irina, Schuepbach, Daniel, Suleman, Sajid, Hargarter, Ludger
Publicado 2016